Drawing for YUVIPTA

USPTO serial 98907719

YUVIPTA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NEHMER, JASON ROBERT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with YUVIPTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Willsey

Peter J. Willsey Kilpatrick Townsend & Stockton LLP701 Pennsylvania Avenue NW, Suite 200Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment of metastasis; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of behcet disease; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; all of the foregoing excluding pharmaceutical preparations for the treatment and prevention of migraines, headaches, and painACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 3, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 8, 2026NOACCORRECTED NOA E-MAILED—
Jan 8, 2026NOACCORRECTED NOA E-MAILED—
Jan 7, 2026CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jan 5, 2026APETASSIGNED TO PETITION STAFF—
Dec 30, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 16, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 5, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 9, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 7, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2025DOCKASSIGNED TO EXAMINER—
Mar 10, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 10, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 10, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 17, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 17, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance